Medtronic Launched Hypertension Treatment Procedure
The Symplicity procedure offers a minimally invasive option for patients failing to manage blood pressure with medication.
Updated on Sept. 28, 2026 in Heart Disease
Live Poll
Would you consider a minimally invasive procedure to manage your high blood pressure?
Medtronic has introduced the Symplicity blood pressure procedure for United States adults struggling with uncontrolled hypertension. The minimally invasive operation helps patients achieve blood pressure control by calming excessively active nerves near the kidneys.
Why it matters
The procedure is designed to help patients reduce their long-term risks of stroke and heart attack. It provides a non-implant alternative for those who remain unable to manage hypertension through lifestyle changes and standard medications.
Approximately 50% of U.S. adults live with high blood pressure, with 75% of those cases currently uncontrolled. Globally, more than 40,000 patients have already received the Symplicity blood pressure procedure.
The players
Medtronic
Medtronic is a global medical technology company that produces the Symplicity Spyral renal denervation system.
Yazmin Rodriguez
Yazmin Rodriguez is a patient who underwent the Symplicity blood pressure procedure in 2024.
The details
The Symplicity Spyral renal denervation system is a minimally invasive operation that does not require an implant. It serves as an adjunctive treatment for patients who struggle with medication adherence, a common issue as nearly 50% of patients stop taking hypertension drugs within one year.
Timeline
In 2024, patient Yazmin Rodriguez underwent the Symplicity blood pressure procedure.
The Big Picture
The introduction of this technology follows a pattern set by the Symplicity Spyral renal denervation system in expanding non-implant options for chronic hypertension management. This marks a shift toward minimally invasive procedural interventions for conditions traditionally treated exclusively with pharmacological daily maintenance.
This procedure offers a new option for individuals who struggle to adhere to daily hypertension medication regimens. Patients should consult their doctors to determine if this non-implant, minimally invasive treatment is appropriate for their specific medical history.
The takeaway
Chronic high blood pressure remains a significant challenge, with nearly 75% of affected adults unable to keep their levels controlled. Patients struggling with medication side effects or adherence should discuss procedural alternatives with their healthcare providers.
Further reading
For more information on managing chronic conditions, visit the Heart Disease section.
More information
For official details, review the renal denervation information and safety guidelines.
Source note: This article includes information reported by Warren County Record.
Live Poll
Would you consider a minimally invasive procedure to manage your high blood pressure?
